Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip
Pharmaceutics · 23.04.2024 · 16 (5) · 574
DOI: 10.3390/pharmaceutics16050574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 23.04.2024. Verfasst von Jung Yoon Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Ministry of Trade, Industry and Energy (MOTIE) and Chungcheongbukdo, Korea Research Institute of Chemical Technology, Research Institute of Bioscience and Biotechnology.
Abstract (Originalsprache)
The blood-brain-barrier (BBB) is made up of blood vessels whose permeability enables the passage of some compounds. A predictive model of BBB permeability is important in the early stages of drug development. The predicted BBB permeabilities of drugs have been confirmed using a variety of in vitro methods to reduce the quantities of drug candidates needed in preclinical and clinical trials. Most prior studies have relied on animal or cell-culture models, which do not fully recapitulate the human BBB. The development of microfluidic models of human-derived BBB cells could address this issue. We analyzed a model for predicting BBB permeability using the Emulate BBB-on-a-chip machine. Ten compounds were evaluated, and their permeabilities were estimated. Our study demonstrated that the permeability trends of ten compounds in our microfluidic-based system resembled those observed in previous animal and cell-based experiments. Furthermore, we established a general correlation between the partition coefficient (Kp) and the apparent permeability (Papp). In conclusion, we introduced a new paradigm for predicting BBB permeability using microfluidic-based systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
- Department of Bioengineering, University of Science and Technology, Daejeon 34113, Republic of Korea.
- Laboratory Animal Resource & Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Republic of Korea.
- Department of Medicinal Chemistry and Pharmacology, University of Science and Technology, Daejeon 34113, Republic of Korea.
- Department of Radiology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju 28644, Republic of Korea.
ORCID-Profile: Dae-Seop Shin, Moonkyu Jeong, Seong Soon Kim, Kyu-Seok Hwang, Kyeong-Ryoon Lee
Förderung
- Korea Ministry of Trade, Industry and Energy (MOTIE) and Chungcheongbukdo
- Korea Research Institute of Chemical Technology
- Research Institute of Bioscience and Biotechnology
- Korean Ministry of Trade, Industry, and Energy (MOTIE) and Chungcheongbuk-do
- Korea Research Institute of Bioscience and Biotechnology
Zitieren
APA
Yang, J. Y., Shin, D. S., Jeong, M., Kim, S. S., Jeong, H. N., Lee, B. H., Hwang, K. S., Son, Y., Jeong, H. C., Choi, C. H., Lee, K. R., & Bae, M. A. (2024). Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip. Pharmaceutics, 16(5), 574. https://doi.org/10.3390/pharmaceutics16050574
Vancouver
Yang JY, Shin DS, Jeong M, Kim SS, Jeong HN, Lee BH, et al. Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip. Pharmaceutics. 2024;16(5):574. doi:10.3390/pharmaceutics16050574
BibTeX
@article{Yang2024,
author = {Yang, Jung Yoon and Shin, Dae-Seop and Jeong, Moonkyu and Kim, Seong Soon and Jeong, Ha Neul and Lee, Byung Hoi and Hwang, Kyu-Seok and Son, Yuji and Jeong, Hyeon-Cheol and Choi, Chi-Hoon and Lee, Kyeong-Ryoon and Bae, Myung Ae},
title = {Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {5},
pages = {574},
doi = {10.3390/pharmaceutics16050574}
}
EUVIMED